跳至主要内容
临床试验/NCT04855188
NCT04855188已完成不适用

A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection

LG Chem1 个研究点 分布在 1 个国家目标入组 394 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
394
试验地点
1
主要终点
WSRS responder rate

研究概览

简要总结

To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 versus YVOIRE volume plus in Nasolabial Folds Injection

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 3 (moderate) or 4 (severe) on the 5-graded WSRS
  • who sign the written informed consent form

排除标准

  • who have received permanent facial implants
  • who have received semi-permanent fillers
  • who have undergone temporary dermal filler treatment within 12 months
  • who have undergone facial tissue augmentation with fat injections, botulinum toxin injections, mesotherapy, or cosmetic procedures within 6 months
  • who have a history of anaphylaxis or allergy to lidocaine, hyaluronic acid (HA) products, or streptococcal protein

结局指标

主要结局

WSRS responder rate

时间窗: 24 weeks after the last injection

the proportion of subjects with ≥ 1 grade improvement on the wrinkle severity rating scale (WSRS) score

次要结局

未报告次要终点

研究者

发起方
LG Chem
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验